Home » Topics » BioWorld

BioWorld
RSS

IMMUCELL GRANT TO TEST ANTIBODY

April 21, 1992

CYGNUS POSTPONES STOCK SALE

April 21, 1992

LIGAND READIES ITS IPO

April 21, 1992

GRANT TO STUDY NERVE DEATH GENES

April 21, 1992

NOVA FILES FOR PERGAMID APPROVAL

April 21, 1992

STOCK SKID SEEMS RELENTLESS

April 21, 1992

FDA PANEL AFFIRMS DDI DECISION

April 21, 1992

APPOINTMENTS AND ADVANCEMENTS

April 20, 1992

TARGETECH PATENT FOR LIVER GENE THERAPY

April 20, 1992

AMBICIN KILLS ULCERATING BACTERIUM

April 20, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...